Studies reveal that even healthy breast tissues may contain cells with genetic changes typical of invasive breast cancer, prompting concerns about false diagnoses. Researchers underscore the need for ...

NewsVoir Mumbai Maharashtra [India]2 Lung cancer remains one of the most prevalent and deadly cancers globally with approximately 22 million new cases diagnosed annually contributing to 18 of all canc ...

A defining feature of many cancers is genomic instability, which refers to the increased likelihood of acquiring mutations during cell division. These alterations can serve as potential biomarkers for ...

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and Cellular Oncogenesis Program, and colleagues have discovered a new approach to ...

Researchers at Saint Louis University's School of Medicine say T-cell dysfunction is leading to an increased risk of cancer ...

Molecular Partners said it expanded an agreement with Orano Med to develop and market Radio-DARPin therapeutics for the treatment of cancer. The biotechnology company said the new agreement will ...

(UCR/Isaac Rodriguez) “This ‘molecular crowbar’ strategy is potentially a promising method in drug discovery and pharmacology ...

--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development ... 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.

The Symposium is hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR).

In drug discovery, targeted protein degradation is a method that selectively eliminates disease-causing proteins. A University of California, Riverside team of scientists has used a novel approach to ...